About Us

DySISmedical is a medical device company that designs, develops, manufactures and markets imaging systems focusing on the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions.

DySISmedical has developed a proprietary technology that has the potential to address a number of diseases affecting millions of people worldwide and costing billions of dollars to healthcare systems.

The first product introduced to the market is DySIS, which assists clinicians with non-invasive, in vivo detection and diagnosis of cancerous and pre-cancerous lesions of the cervix. DySIS provides advanced tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia.

DySIS is CE-marked in Europe, and its ability to provide significantly improved performance argues strongly for its adoption as the standard of care in colposcopy.

Vision

To be the global leader in automated optical molecular imaging technologies for medical diagnostic and screening applications.

Mission

DySISmedical is committed to saving lives through the early detection and diagnosis of disease using biophotonic innovations.

Structure

DySISmedical comprises two companies:

DySISmedical Ltd, based in Edinburgh, UK (Global Headquarters)

DySISmedical SA, based in Athens, Greece (Southern European Office)